(Q51391081)

4 April 2018

title

Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. (English)

1 reference

4 April 2018

1 reference

2

Kaasa S

1 reference

4 April 2018

Klepstad P

1

1 reference

4 April 2018

Skauge M

series ordinal

3

1 reference

4 April 2018

Borchgrevink PC

series ordinal

4

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

4 April 2018

Acta Anaesthesiologica Scandinavica

published in

1 reference

4 April 2018

volume

44

1 reference

4 April 2018

issue

6

1 reference

4 April 2018

page(s)

656-664

1 reference

4 April 2018

Continuing care for cancer pain relief with oral morphine solution. One-year experience in a regional cancer center

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

Controlled-release morphine (MST Contin) in advanced cancer. The European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

Pain, the physiological antagonist of opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

The management of symptoms in advanced cancer: experience in a hospital-based continuing care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

7 January 2021

Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

7 January 2021

Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

7 January 2021

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

7 January 2021

The incidence of narcotic-induced emesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

7 January 2021

Antiemetics for terminal cancer patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2000.440605.X

7 January 2021

10.1034/J.1399-6576.2000.440605.X

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018